Develops and distributes CONTOUR brand blood glucose monitoring systems and digital diabetes management solutions.
Ascensia Diabetes Care Holdings AG
Basel (Switzerland) · Parsippany, NJ (USA)New on Amplifa
About Ascensia Diabetes Care
Ascensia Diabetes Care is a global company focused exclusively on improving the health and quality of life of people with diabetes. The company was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings (now PHC Holdings) and is headquartered in Basel, Switzerland. The portfolio includes the CONTOUR family of blood glucose monitoring systems, digital diabetes management solutions like the CONTOUR DIABETES App and the GlucoContro.online platform, as well as CONTOUR COMFORT pen needles. The products are distributed in over 90 countries. Reflecting on a history of over 80 years of innovation in diabetes management – from Clinitest (1941) to the first portable blood glucose meter (1969) to No-Coding technology (2003) – the company develops high-quality solutions and precision tools for daily diabetes care.
- Site
- Basel
- Processes
- Diabetes Management Solutions (digital platforms like GlucoContro.online), CONTOUR Pen Needles
- Materials
- Blood Glucose Monitoring Systems, Diabetes Management Software, Pen Needles
- Founded
- 2016
- Industries
- Diabetes Care, Medical Technology, Blood Glucose Monitoring
- 01
Research and Development
- 02
Product Development and Approval
- 03
Manufacturing (with partners)
- 04
Distribution in over 90 countries
- 05
Digital Data Management Platforms
- 06
Customer Support
Products and Technologies
Blood Glucose Monitoring Systems
CONTOUR and CONTOUR NEXT monitoring systems featuring functions like No Coding technology and low blood volumes.
Diabetes Management Software
App- and browser-based platforms such as the CONTOUR DIABETES App and GlucoContro.online for recording and analyzing measurement values.
Pen Needles
CONTOUR COMFORT Pen Needles for compatibility with common pen injectors.
Locations
Basel
CHCorporate Headquarters
Parsippany, NJ
USU.S. Headquarters
Products
Inside the production
Industries
Additional services
History
- 1941
Development of Clinitest, the first tablet test for measuring reducing substances in urine like glucose
- 1969
Introduction of the Ames Reflectance Meter, the first portable blood glucose meter (by the former Ames division)
- 1993
Introduction of Glucometer Elite, the first meter with Sip-in technology and the first Low-Volume system (3 microliters)
- 2003
Introduction of blood glucose meters with No Coding technology, including BREEZE and CONTOUR
- 2012
Introduction of the first CONTOUR NEXT blood glucose meters
- 2016
Founding of Ascensia Diabetes Care through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings (PHC Holdings)
- 2018
Launch of an enhanced CONTOUR DIABETES App
- 2021
Launch of the GlucoContro.online diabetes data management platform
- 2026
Launch of CONTOUR COMFORT Pen Needles